RecallDepth
Class II Terminated

GSMS: Ranitidine Capsules 300 mg, Rx only, 100 count bottles (NDC 51407-098-01) Manufactured by Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520; Packaged by GSMS, Incorporated, Carmillo, CA 93012 USA.

This recall has been terminated (originally issued November 20, 2019).

Company
Golden State Medical Supply Inc.
Recall Initiated
November 6, 2019
Posted
November 20, 2019
Recall Number
D-0308-2020
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Camarillo, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Distribution

AZ, IA, MA, MO

Lot / Code Info

Lot Codes: GS023971, Exp. 10/31/2020; GS025527, Exp. 10/31/2020; GS025526, Exp. 10/31/2020; GS026114, Exp. 10/31/2020; GS025813, Exp. 10/31/2020; GS026189, Exp. 10/31/2021; GS027555, Exp. 7/31/2021; GS026190, Exp. 5/31/2021; GS026220, Exp. 05/31/2021; GS026584, Exp. 05/31/2021; GS027139, Exp. 05/31/2021; GS027554, Exp. 05/31/2021.

More recalls by Golden State Medical Supply Inc.

View all recalls by this company →

Other recent Class II Drug recalls